ZA706931B - Pharmaceutical composition useful for inhibiting fatty acid synthesis - Google Patents

Pharmaceutical composition useful for inhibiting fatty acid synthesis

Info

Publication number
ZA706931B
ZA706931B ZA706931A ZA706931A ZA706931B ZA 706931 B ZA706931 B ZA 706931B ZA 706931 A ZA706931 A ZA 706931A ZA 706931 A ZA706931 A ZA 706931A ZA 706931 B ZA706931 B ZA 706931B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
fatty acid
acid synthesis
composition useful
inhibiting fatty
Prior art date
Application number
ZA706931A
Other languages
English (en)
Inventor
J Lowenstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA706931B publication Critical patent/ZA706931B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA706931A 1969-10-29 1970-10-12 Pharmaceutical composition useful for inhibiting fatty acid synthesis ZA706931B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87241369A 1969-10-29 1969-10-29

Publications (1)

Publication Number Publication Date
ZA706931B true ZA706931B (en) 1971-07-28

Family

ID=25359519

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA706931A ZA706931B (en) 1969-10-29 1970-10-12 Pharmaceutical composition useful for inhibiting fatty acid synthesis

Country Status (9)

Country Link
BE (1) BE758122A (xx)
CA (1) CA923425A (xx)
DE (1) DE2052131A1 (xx)
FR (1) FR2070174B1 (xx)
GB (1) GB1311015A (xx)
IE (1) IE34648B1 (xx)
IL (1) IL35477A (xx)
NL (1) NL7015348A (xx)
ZA (1) ZA706931B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792180A (fr) * 1971-12-02 1973-06-01 Hoffmann La Roche Derives de l'acide citrique
FR2716374B1 (fr) * 1994-02-18 1996-04-19 Sederma Sa Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
ES2106689B1 (es) * 1996-04-18 1998-05-16 Cabo Soler Jose Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.
US20030004215A1 (en) * 2001-06-15 2003-01-02 Van Laere Katrien Maria Jozefa Dietetic preparation and method for inhibiting intestinal carbohydrate absorption

Also Published As

Publication number Publication date
NL7015348A (xx) 1971-05-04
DE2052131A1 (de) 1971-05-06
FR2070174A1 (xx) 1971-09-10
IL35477A (en) 1973-08-29
IL35477A0 (en) 1970-12-24
FR2070174B1 (xx) 1974-02-22
BE758122A (fr) 1971-04-28
GB1311015A (en) 1973-03-21
IE34648B1 (en) 1975-07-09
CA923425A (en) 1973-03-27
IE34648L (en) 1971-04-29

Similar Documents

Publication Publication Date Title
ZA713539B (en) Pharmaceutical compositions
IE34966L (en) Pharmaceutical composition containing substitiuted¹biguanides
ZA717083B (en) New pharmaceutical compositions
IE35838B1 (en) Pharmaceutical compositions
IL38090A0 (en) Pharmaceutical compositions containing nicotinic acid derivatives
IL37013A (en) Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
ZA706931B (en) Pharmaceutical composition useful for inhibiting fatty acid synthesis
ZA702530B (en) Improvements relating to pharmaceutical compositions comprising beta-adrenolytics
MY7700009A (en) Pharmaceutical compositions containing bischromonyloxy compounds
ZA718246B (en) Compositions of matter
IL38375A0 (en) Pharmaceutical compositions containing pregnane compounds
GB1370479A (en) Process for producing pharmaceutical compositions
MY7500154A (en) 3-quinoline-carboxylic acid compounds process for their manufacture and compositions containing them
GB1373913A (en) Pharmaceutical compositions
ZA715832B (en) Pharmaceutical compositions
CY845A (en) Antiineectious pharmaceutical compositions
IL37353A0 (en) Fungicidal compositions containing esters of phenylazoalkenoic acids
ZA704998B (en) Pharmaceutical compositions
ZA716461B (en) Pharmaceutical compositions
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid
IL36009A0 (en) Pharmaceutical compositions containing 9-azolyl-(1)-fluorene-9-carboxylic acid derivatives
ZA695903B (en) Pharmaceutical compositions
IL35724A0 (en) Pharmaceutical compositions containing prostaglandin derivatives
IE34289L (en) Phenyl-imidazolyl fatty acid derivatives
IE35713L (en) Pharmaceutical compositions